Glucose uptake is crucial for providing both an energy source and a signal that regulates cell proliferation. Therefore, it is important to clarify the mechanisms underlying glucose uptake and its transmission to intracellular signaling pathways. In this study, we searched for a novel regulatory factor involved in glucose-induced signaling by using Saccharomyces cerevisiae as a eukaryotic model. Requirement of the extracellular protein Ecm33 in efficient glucose uptake and full activation of the nutrient-responsive TOR kinase complex 1 (TORC1) signaling pathway is shown. Cells lacking Ecm33 elicit a series of starvation-induced pathways even in the presence of extracellular high glucose concentration. This results in delayed cell proliferation, reduced ATP, induction of autophagy, and dephosphorylation of the TORC1 substrates Atg13 and Sch9.
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Glucose uptake is crucial for providing both an energy source and a signal that regulates cell proliferation. Therefore, it is important to clarify the mechanisms underlying glucose uptake and its transmission to intracellular signaling pathways. In this study, we searched for a novel regulatory factor involved in glucose-induced signaling by using Saccharomyces cerevisiae as a eukaryotic model. Requirement of the extracellular protein Ecm33 in efficient glucose uptake and full activation of the nutrient-responsive TOR kinase complex 1 (TORC1) signaling pathway is shown. Cells lacking Ecm33 elicit a series of starvation-induced pathways even in the presence of extracellular high glucose concentration. This results in delayed cell proliferation, reduced ATP, induction of autophagy, and dephosphorylation of the TORC1 substrates Atg13 and Sch9.
Keywords: glucose uptake; metabolism; nutrient signal Glucose is a major carbon source, the most preferred by cells. After incorporation into cells, glucose can be converted not only to an energy source but also to a 'regulatory signal' that controls cellular physiology including cell growth and metabolism. Thus, an effective incorporation of extracellular glucose and the subsequent response to the glucose signal are crucial for organismal physiology. In mammals, a defect in either the sensing or the incorporation of glucose disturbs optimized cellular physiology, resulting in metabolic diseases [1, 2] . The most fundamental but not fully understood questions are how cells effectively sense/incorporate extracellular glucose and how cells respond to a glucose-induced signal to optimize the intracellular physiology. It is, therefore, important to identify still unknown molecules that are involved in effective glucose uptake and optimization of the intracellular response.
The conserved Ser/Thr kinase, TOR complex 1 (TORC1) plays a central role in optimization of the major physiological responses to nutrient signal, such as cell proliferation, translation, metabolism, and autophagy [3] [4] [5] [6] . For carbon-source signaling, protein kinase A (PKA) and AMPK/Snf1 kinase are known to be important, whereas TORC1 is important for nitrogensource signaling [7] . However, recent studies have suggested that TORC1 is also involved in glucose signaling, at least in part, by cross talking with Snf1 and PKA [3, 8, 9] . Like AMPK in mammals, yeast AMPK/Snf1 phosphorylates Kog1, a conserved TORC1 subunit, leading to TORC1 inactivation upon glucose deprivation [10] . While Snf1 is activated upon glucose deprivation that increases ADP/ATP and AMP/ATP ratios [3] , PKA is activated in the presence of high glucose that increases cAMP [7, 11] . It has also been suggested that Abbreviations 2DG, 2-deoxyglucose; Ams1, a-mannosidase; HA, influenza hemagglutinin; HXT, hexokinase; Pep4, proteinase A; PKA, the protein kinase A; pNP, para-nitrophenyl; TORC1, the target of rapamycin complex 1. glucose activation of the PKA pathway may also play a role in the inactivation of Snf1 in the presence of glucose [12] . Collectively, TORC1 may interplay with Snf1 and PKA to control physiological responses appropriate for carbon and/or energy availability.
Only few regulatory factors involved in the TORC1 signaling pathway have been identified [6, 13, 14] . The known regulators, Gtr1/Gtr2, Npr1/2, and Rho1 have strong impact on TORC1 signaling in a nitrogen starvation condition but not in a glucose starvation condition [10] . In mammals, the uncontrolled TORC1 activity and/or the impairment of nutrient-signal response are known to be correlated with cancer and metabolic diseases [4, 15] . The regulatory mechanism of mTOR has been one of the major therapeutic target for these diseases.
In this study, with the aim to identify a novel molecule involved in the optimization of glucose-induced signaling, we utilized the system of budding yeast Saccharomyces cerevisiae as a eukaryotic model organism. This unicellular model organism is suited for this purpose since yeast cells respond to extracellular nutrients. Here, we report that a GPI-anchored protein of unknown function, Ybr078w/Ecm33 in S. cerevisiae, is a novel factor facilitating nutrient responses through TORC1 signaling. We read out the activity of the TORC1 signaling pathway by means of monitoring the intracellular activity of a-mannosidase (Ams1), since we have previously shown that Ams1 was induced by inactivation of TORC1 [16] . Our results suggested that Ybr078w/Ecm33 is required for efficient glucose uptake to fully activate TORC1 signaling in a nutrient-rich condition.
Materials and methods

Yeast strains, growth conditions, and plasmids
The S. cerevisiae strains used in this study are listed in Table S1 . Gene deletions were performed by a standard PCR-based procedure [17] . Yeast strains were grown at 30°C in YPD (1% yeast extract, 2% peptone, and 2% glucose) or synthetic medium (0.67% yeast nitrogen base, 2% glucose, and auxotrophic amino acids). For starvation, YPGlc (1% yeast extract and 2% peptone) or SD-N (0.17% yeast nitrogen base without ammonium sulfate and amino acids, and 2% glucose) were used. Cells grown in YPD to OD 600 = 1.0 were used for the following assay. If required, YPD was changed to starvation medium, or rapamycin (Funakoshi) was added to the medium at 2-200 ngÁmL
À1
. A plasmid encoding the GFP-tagged Ams1 with an endogenous promoter (pRS426-Ams1-GFP) was constructed as described previously [16] . pRS416-Sch9-3HA was kindly provided by Robbie Loewith (University of Geneva).
pRS315-HA-Atg13 and pRS426-GFP-Atg8 were kindly provided by Daniel Klionsky (University of Michigan).
Assay for a-mannosidase activity As a first step, 50 OD 600 cells were disrupted with glass beads in 600 lL of lysis buffer [20 mM PIPES-NaOH (pH 6.8), 1 mM EDTA, 1 mM PMSF, 1% TritonX100]. The cell-free extracts were mixed with 1 mM para-nitrophenyl (pNP)-a-D-mannopyranoside (Tokyo Chemical Industry, Tokyo, Japan) in 40 mM potassium phosphate buffer (pH 7.5) containing 1 mM EDTA and 1 mM PMSF, and incubated at 30°C for 60 min. Enzyme reactions were stopped by adding 250 mM glycine-Na (pH: 10.0) to the reaction mixtures. The amount of p-nitrophenol was measured at A 400 and the protein concentrations were determined using BCA assay kit (Thermo Scientific, Waltham, MA, USA) according to the manufacturer's instructions. One unit was defined as the amount of enzyme that catalyzes hydrolysis of 1 nmol of p-nitrophenol per minute. Each assay was repeated at least three times, and the standard deviation was calculated from at least three independent experiments.
Immunoblotting
Cells were collected and proteins were precipitated by adding 10% of trichloroacetic acid and washing with acetone. For monitoring the phosphorylation of Sch9, 6% of trichloroacetic acid was added to the culture medium, according to the previously reported procedures [18] . Then, the pelleted cells were washed with acetone and lysed with glass beads in urea buffer [50 mM Tris (pH 7.5), 5 mM EDTA, 6 M urea, 1% SDS, 10 mM NaF, 10 mM NaN 3 , 10 mM p-nitrophenylphosphate, 10 mM Na 2 P 2 O 4 , and 10 mM b-glycerophosphate, 19 phosphatase inhibitor cocktail, 19 protease inhibitor cocktail and 1 mM PMSF]. After heated at 65°C for 10 min, samples were treated with 1 mM 2-nitro-5-thiocyanatobenzoic acid (NTCB) in 0.1 M CHES (pH10.5) for overnight. Protein extracts were subjected to SDS/PAGE followed by immunoblotting with anti-influenza hemagglutinin (HA) mouse monoclonal antibody (F-2; Santa Cruz Biotechnology, Dallas, TX, USA) or anti-GFP mouse monoclonal antibody (JL-8; Clontech, Mountain View, CA, USA). Anti-Pgk1 mouse monoclonal antibody (22C5D8; Abcam, Cambridge , UK) was used as the protein-loading control. Immunoreactive bands were visualized using ChemiDoc TM XRS+ (BioRad, Berkeley, CA, USA) with an ECL Western Blotting Detection kit (Amersham, Buckinghamshire, UK).
Assay for autophagy
For monitoring autophagy, the alkaline-phosphatase activity of Pho8Δ60 [19] and processing of GFP-Atg8 [20] were assessed according to the reported protocols.
ATP assay
2.0 OD 600 cells grown in YPD were washed with water and suspended in 80 lL of ice cold 5% trichloroacetic acid for 30 min. After centrifugation (18 000 g, 10 min), the supernatant was used for assay using the ATP Assay Kit (BioVision, Milpitas, CA, USA) according to the manufacturer's protocol with a microplate analyzer (Infinite200; Tecan, M€ annedorf, Switzerland) in fluorometric mode (Ex/ Em = 535/587 nm).
Glucose uptake assay 6.0 OD 600 cells grown in YPD were washed with PBS and incubated with 20 mM 2-deoxyglucose (2DG) at 30°C for 10 min. The 2DG uptake was stopped by adding 500 mM glucose. Cells were washed with PBS and disrupted with glass beads in PBS containing 0.8% TritonX100. The samples were heated at 80°C for 15 min, centrifuged at 14 000 r.p.m. for 5 min, and the supernatant was used for an assay using 2DG uptake measurement kit (Cosmobio, Tokyo, Japan) according to the manufacturer's protocol with a microplate analyzer (Infinite200; Tecan) in fluorometric mode (Ex/Em = 540/590 nm).
Results
Ecm33 is required for suppression of Ams1 under the nutrient-rich condition
In a previous study, we have shown that the intracellular activity of Ams1 in S. cerevisiae was tightly suppressed under the nutrient-rich condition but enhanced strikingly upon glucose deprivation [16] . As well as aminopeptidase 1 (Ape1), Ams1 is known to be a substrate for autophagy that is transported from the cytosol into the vacuoles [21] [22] [23] . Ams1 was upregulated most strikingly by glucose starvation but also upregulated by nitrogen starvation [16] . In conjunction with autophagy, the enzymatic activity of Ams1 was partially enhanced by a proteinase A (Pep4)-dependent processing in the vacuoles [16] . It was suggested that the regulation of Ams1 was conducted by TORC1, synchronized with PKA/Snf1 pathways [16] . It is known that TORC1 is activated in the presence of abundant nutrient, but suppressed by deprivation of either the nitrogen source or the carbon source [3, 8, 24] . However, the regulatory mechanism for TORC1 signaling has not been completely solved, because there still exist unidentified molecules involved in incorporation/transmitting the extracellular nutrient into the intracellular signaling pathways.
The TORC1-dependent regulation of Ams1 enabled us to read out the activity of TORC1 pathway by quantifying the intracellular Ams1 activity from the cell-free extract using pNP-a-mannopyranoside as a substrate. Thus, we applied this robust Ams1 assay to a series of knockout strains of S. cerevisiae to find out a novel molecule involved in a carbon-source-dependent regulation of TORC1. We examined about 120 knockout strains of function-unknown genes which have sequence similarity with carbohydrate-related modules (Fig. S1A) . As a result, deletion mutant of Ybr078w/Ecm33 showed an about 10-fold increase of the Ams1 activity compared with that of the WT in a nutrient-rich condition (Figs 1A and S1B). In consistency with our previous results, the Ams1 activity was low under the nutrient-rich condition, but significantly increased upon glucose starvation (Fig. 1A) . In a glucose-starved condition, a significant change was not observed between the Ams1 activity of WT cells and that of ybr078w/ecm33D cells. These results suggest ) for 4 h. Ams1-GFP (~150 kDa) and processed form of Ams1-GFP (~100 kDa) were detected by using anti-GFP antibody. Pgk1 signals at each time point were detected as a loading control by using anti-Pgk1 antibody.
that Ybr078w/Ecm33 is required for suppression of Ams1 under the nutrient-rich condition. We also examined the change of the protein level of GFPtagged Ams1 protein in a nutrient-rich condition. We have previously shown that the amount of Ams1 protein as well as its Pep4-dependent processing was suppressed by TORC1 [16] . Consistent to our previous results, the protein amount of Ams1-GFP in a nutrient-rich condition was low, but it was significantly increased after rapamycin treatment to inhibit TORC1 (Fig. 1B) . It was found that the protein amount of Ams1-GFP under the nutrient-rich condition increased significantly by deletion of Ybr078w/Ecm33. Since Ams1 is a substrate for autophagy, the processed form of Ams1-GFP derived from Pep4-dependent processing in the vacuoles [16, [21] [22] [23] . In ybr078w/ecm33D, the processed form of Ams1-GFP was also increased (Fig. 1B) , suggesting that the autophagic transport of Ams1 into the vacuoles was facilitated.
As to the Ybr078w/Ecm33, the detailed intracellular function has not been examined, but it has been reported that this gene encodes a GPI-anchored protein localized on the cell surface [25] . In addition, it was reported that the deletion of this gene showed a decreased growth rate in a nutrient-rich medium. As reported previously, the ybr078w/ecm33Dstrain showed a reduced growth rate under the nutrition-rich condition (Fig. S2) . It has been found that TORC1 drives cell growth in response to nutrition. These results raised the possibility that deletion of Ybr078w/Ecm33 could cause inhibition of the TORC1 pathway that resulted in delayed cell proliferation and enhancement of the Ams1 activity.
Ecm33 is required for an effective activation of the TORC1 signaling pathway
We next assessed if Ybr078w/Ecm33 could be involved in incorporation and/or transmission of external nutrition into the intracellular TORC1 signaling pathway. To read out the TORC1 activity, we monitored the phosphorylation status of TORC1 substrate. Among several substrates of TORC1, Atg13 is known as a direct substrate of TORC1, and the dephosphorylation of Atg13 leads to the induction of autophagy [26] . As reported previously, Atg13 is highly phosphorylated under the nutrient-rich condition in the WT cells. Thus, phosphorylation species of Atg13 was detected as mobility shift (Fig. 2A, lane 1,  upper band) . In contrast, Atg13 was dephosphorylated after rapamycin treatment (Fig. 2A, lane 2, lower band) . Remarkably, in comparison with the WT cells, Atg13 was dephosphorylated in ecm33D cells under nutrient-rich condition (Fig. 2A, lane 3) . We examined this further by using serial dilution of rapamycin. As a result, both in the WT cells and in the mutant cells, Atg13 was dephosphorylated with the increase of rapamycin (Fig. 2B) . In each condition, the phosphorylation level of Atg13 was decreased in ecm33D compared to that in the WT cells, but the difference was more significant as rapamycin decreased. For further confirmation, we also examined the phosphorylation of Sch9, another reported substrate of TORC1 [18] . As reported previously, the C-terminal fragment of Sch9-3HA was partially phosphorylated under the nutrient-rich condition in the WT cells (Fig. 2C,  lane 1, upper band) , but dephosphorylated after rapamycin treatment (Fig. 2C, lane 3) . On the other hand, in ecm33D cells, the C-terminal fragment of Sch9-3HA was almost dephosphorylated under the nutrient-rich condition without rapamycin (Fig. 2C, lane 2) . These results suggested that Ecm33 is required for effective activation of TORC1 under the nutrient-rich condition.
Deletion of Ecm33 induces autophagy under the nutrient-rich condition
It is known that, from yeast to mammals, the induction level of autophagy is strictly downregulated by TORC1 [3, 5, 7] . It has also been reported that autophagy was induced upon TORC1 inhibition by the deprivation of either the external nutrient source, such as nitrogen, carbon and phosphate [24, 27] . Moreover, our results suggest that Ybr078w/Ecm33 is involved in the phosphorylation of Atg13, downstream of TORC1 signaling response to nutrient. Accordingly, we next examined whether the deletion of Ybr078w/Ecm33 could induce autophagy. In this experiment, we carried out an alkaline-phosphatase (ALP) assay using a pho8D60 strain to quantify the magnitude of autophagy [19, 27] . Deletion of the N-terminal cytosolic tail and transmembrane domain of Pho8 prevents the protein from entering the secretory pathway. Consequently, the cytosolic mutant form is delivered to the vacuole via macroautophagy, where proteolytic removal of the C-terminal propeptide by the vacuolar Prb1 generates the active enzyme. Similar to the intracellular Ams1 activity shown in Fig. 1A , the ALP activity under the nutrient-rich condition was significantly elevated in the ecm33D cells compared to that of the WT cells (Fig. 3A) . Under the nitrogen-starved condition, the ALP activity was not significantly changed by the deletion of Ecm33. To further examine the autophagic flux, we carried out the GFP-Atg8 processing assay. Since an ubiquitin-like protein, Atg8, is a key component of the autophagosomal membrane, an N-terminal fusion of GFP (GFP-Atg8) can be used as a marker of the autophagosome [28] . Atg8 remains associated with the completed autophagosome until vacuolar delivery, the generation of free GFP in the vacuoles is indicative of autophagic flux. As a result, free GFP and GFP-Atg8 were clearly increased by the deletion of Ecm33 in a nutrient-rich conditions without rapamycin [Rap(À)]. In the WT cells, free GFP was generated under rapamycin-treated condition [Rap (+)], but not under the basal condition without rapamycin (Fig. 3B, lane 1) . These results suggest that autophagy is induced by the deletion of Ecm33 in nutrient-rich condition. ) for 2 h. The ratio of the signal of total GFP (GFPAtg8 and free GFP)/Pgk1 was quantified using IMAGEJ, and the values are indicated below the panel.
primarily in response to a carbon-source starvation, Ecm33 would presumably be involved in response to carbon source. To examine this possibility, we quantified the intracellular ATP in vegetative cells under the nutrient-rich condition. In this experiment, deletion mutant of Atp7 was introduced as a control that would demonstrate the reduction of the intracellular ATP. Atp7 is known to be required for ATP synthesis, since it consists of the ATP synthase complex localized at the mitochondrial inner membrane [29] . As a result, in early growing cells cultured for 5 h, the intracellular ATP level in the atp7D cells clearly dropped down by 70% of that of the WT cells (Fig. 4A) . The ATP level was partially reduced (~25%) in ecm33D cells compared with that of the WT cells. After cultivation in a nutrient-rich condition for 24 h, a more significant reduction (~75%) of ATP was observed in the ecm33D cells (Fig. 4B ). In the WT cells, the ATP level was almost kept after long cultivation, as the ATP level was about 35 lM in either the 5-h cultured cells or the 24-h cultured cells. However, the intracellular ATP in the ecm33D cells cultured for 24 h was reduced to < 40% of ecm33D cells cultured for 5 h.
Next, we examined whether the productivity of ATP was reduced in ecm33D cells. To evaluate this, we assessed the glucose uptake into the cells by monitoring the uptake of 2DG [30] . We compared the 2DG uptake between WT and ecm33D using cells grown under the nutrient-rich condition for 5 h, in which the difference of intracellular ATP was observed (Fig. 4A) . It was suggested that the 2DG uptake in ecm33D was reduced about 70% of that in the WT cells (Fig. 4C) . To rule out the possibility that a slow growing mutant takes up nutrients slowly and has low TORC1 activity, we also examined other mutant strains with slow growth. It was found that bud16D and slm6D, mutants of gene involved in bud-site selection [31] and in actin cytoskeleton organization [32] , respectively, grew very slowly in a nutrient-rich condition like ecm33D (Fig. S2A) . In contrast to ecm33D, neither the bud16D nor slm6D showed significant reduction in 2DG uptake (Fig. S2B) . Consequently, phosphorylation of either the TORC1 substrate, Atg13 or Sch9, in bud16D and slm6D cells showed similar pattern to that in the WT cells under the nutrient-rich condition (Fig. S2C,D) . Thus, a slow-growing mutant does not always result in reduced glucose uptake, causing low TORC1 activity. These results suggested that Ecm33 is required for the efficient uptake of glucose under the nutrient-rich condition. Hence, the starvation-induced TORC1 signaling occurred in the ecm33D cells, despite the presence of abundant glucose in the environment.
Discussion
Cells have evolved to import extracellular glucose effectively and optimize the cellular physiology appropriate for glucose levels outside of the cells. In this study, we found that Ecm33 in yeast is a novel factor which plays a role in effective glucose uptake to precisely control the intracellular responses, by means of monitoring the intracellular Ams1 activity. It is suggested that Ecm33 is required for full activation of the intracellular TORC1 signaling response to nutrients, which drives cell proliferation and suppresses catabolic processes, such as intracellular mannoside metabolism and macroautophagy (Fig. 5) . Our data suggest that at least one of the novel intracellular functions of Ecm33 is to play a role in efficient glucose uptake/transmission to activate the TORC1 pathway. However, our current data do not clarify the direct target of Ecm33, and how Ecm33 itself acts for efficient glucose uptake. Given that S. cerevisiae has multiple hexose transporters (HXTs) some of which are functionally redundant, Ecm33 presumably may not directly transport glucose. The most plausible explanation may be that Ecm33 supports the function and/or the suitable localization of hexose (glucose) transporters on the cell surface. The number of each glucose transporters on the plasma membrane is appropriately controlled from the concentration of extracellular glucose, not only by transcriptionally but also by ubiquitindependent degradation through endocytosis [1, 33] . However, in our microscopy analysis, the GFP-fusion proteins of either the HXT1 or the HXT3, known as low affinity glucose transporters induced by high concentration of glucose, were observed around the cell surface in the ecm33D cells similarly to that in the WT cells (data not shown). Function of HXTs might also facilitated by the combined action of different regulatory mechanisms, including unknown post-translational modulations, such as localization change, modulation of affinity for glucose and interaction between transporters. Some GPI proteins in mammals, such as CD59, are known to be concentrated transiently on the plasma membrane to form a raft to retain membrane proteins on the cell surface for efficient signal transduction [34] . Another possibility might be that Ecm33 affects membrane dynamics on the cell surface.
The molecular function of Ecm33 is difficult to predict from genetic information. Nevertheless, the Ybr078w/Ecm33 gene shows a slight homology with glycoside hydrolase unassigned to GH family (the CAZy database: www.cazy.org). Ecm33 was previously assigned to one of the extracellular mutant (ECM) proteins from large-scale identification for mutants which affected cell wall synthesis [35] . It was reported that, in the ecm33D cells, the sugar composition of cell walls (the ratio of mannose per glucose) was changed to be zymolyase hypersensitive. Since our results show that glucose uptake is significantly reduced in the ecm33D cells, it seems to be reasonable to think that deprivation of the intracellular glucose results in the impairment of cell wall synthesis. However, other possibility cannot be ruled out that this protein may be involved in cell wall glycan assembly on the cell surface. A homologous gene to Ybr078w/Ecm33 was not conserved in mammals but conserved in broad species of yeasts as well as fungi, suggesting that the function of this gene is likely to be characteristic for microorganisms having a cell wall.
While the TORC1 pathway has been highlighted to play an important role in nitrogen and amino acid responses, it has been reported that TORC1 also Ecm33 is involved in efficient uptake of glucose to produce ATP. Subsequently, it leads activation of the intracellular TORC1 signaling pathways, presumably via Snf1 and PKA, to facilitate cell proliferation and suppress mannoside degradation and autophagy.
responds to carbon sources as well as other environmental stresses [8, 24, 27] . However, it remains largely unclear how these additional signals are transmitted to TORC1 and how they influence the TORC1 pathway. Our results suggest that Ecm33 facilitates glucose incorporation to fully activate TORC1 signaling in the presence of glucose. In the ecm33D cells, cell proliferation, Ams1 induction, autophagy and Atg13 phosphorylation, known as the downstream outputs from TORC1, are changed. It has been reported that both Snf1 and PKA affect TORC1 signaling on the upstream, although there is a conflict for the relationship between these two kinases and TORC1 [3, [8] [9] [10] 23] . From our data, it seems to be reasonable to think that Ecm33 may be involved in the carbonsource-dependent regulation of TORC1 signaling, at least in part, via Snf1 and PKA. Since deletion of Ecm33 results in the reduction of ATP level, this would affect Snf1 as well as PKA.
In conclusion, this study shows that Ecm33 is involved in regulating intracellular TORC1 signaling by facilitating efficient uptake of extracellular glucose, the most vital nutrient. Identification of the regulatory factors involved in TORC1 signaling is one of the most important tasks. However, the current method to assess the intracellular TORC1 signaling is performed by monitoring the phosphorylation change of TORC1 substrates by the band shift assay on western blot, which tends to be qualitative rather than quantitative. In this study, by quantifying the intracellular Ams1 activity, Ecm33 was identified as a novel factor related to TORC1 signaling. Thus, this simple method would provide another convenient tool for screening a new candidate involved in TORC1 signaling.
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